Dear Democracy Now! Visitor: We are an independent, ad-free daily news program that serves millions of viewers and listeners each month. In this US election year, Democracy Now! is more important than ever. For 20 years, we’ve put a spotlight on corporate and government abuses of power. We lift up the stories of ordinary people working to make change in extraordinary times. We do all of this with just a fraction of the budget and staff of a commercial news show. We do it without ads, corporate sponsorship or government funding. How is this possible? Only with your support. A generous funder will match your donation dollar for dollar if you donate right now. That means when you give $10, your donation will be worth $20. Pretty exciting, right? So, if you've been waiting to make your contribution to Democracy Now!, today is your day. It takes just a couple of minutes to make sure that Democracy Now! is there for you every day.

Your Donation: $

2 Cancer Patients Arrested Protesting Drug Provisions in TPP

February 05, 2016
Hdls11 tpp

Protests against the Trans-Pacific Partnership trade deal continue after the 12-nation pact was signed Thursday in New Zealand. In Washington, D.C., two cancer patients were arrested after linking arms and refusing to leave the lobby of the building that houses PhRMA, the trade association that has pressed for expanded monopolies in the TPP. Zahara Heckscher spoke as she was arrested.

Zahara Heckscher: "I have advanced breast cancer, and I’m here to tell Congress, 'Reject the Trans-Pacific Partnership.' It hurts people with cancer. It would make cancer medicines even more expensive. We can’t afford the TPP. People with cancer can’t afford the TPP. It’s a life-and-death issue."

To see our interview with Zahara Heckscher, you can go to

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.